Search
Press Releases
Search Archive:  

 

Technological Advancements to Drive US Stem Cell Therapy Market

Feb 17, 2010
Share |
 

The stem cells therapy market has been undergoing different research levels worldwide to exploit the true potential of therapy. It is an important market in the US that has witnessed considerable investments and ability to lead the other developed markets. The US stem cells therapy market has shown remarkable growth since 2005 when the first stem cell product was introduced in the market. According to our research report "US Stem Cell Market Analysis", the stem cell therapy market in the US is expected to grow at a CAGR of 38% during 2009-2012 to reach around US$ 498 Million by 2012.

The stem cell market will not only generate huge revenue during forecast but also register strong growth in technological areas. On the technological front, our team of industry experts has segmented the US stem cell market by Therapeutic Banking and Cellular Therapeutics. Both the segments will witness strong growth to keep pace with rising demand for better treatments. As per our research, the Therapeutic Banking and Cellular Therapeutic markets are expected to grow at a CAGR of around 21% and over 50% respectively between 2009 and 2012. Various factors that will drive future growth of these technologies have been discussed in detail.

The report has also identified the emerging segments in the stem cell market along with their market potential to provide effective and reliable treatment for chronic diseases. The segments covered in the report are - Spinal Cord Injury, Biological and Associated Hardware, Myocardial Infarction and Limb Ischemia. The report will help clients to understand the market dynamics and align their investment strategies.
 
"US Stem Cell Market Analysis", provides comprehensive information about the US stem cell market which will help clients gain an in-depth understanding of the prevailing market trends and developments going on across the country. Besides, we have done a detailed analysis of various factors which will foster growth in the US stem cell industry. We have also included a separate section of competitive landscape that furnishes information about the key players, their business strategies and performance.

For more information visit: http://www.rncos.com/Report/IM191.htm


Related Press Releases:
» Indian Diagnostic Market Poised to Grow at 16% CAGR
» Next-Generation Sequencing Market to Touch US$ 2 Billion-Mark by 2015
» European Regenerative Medicine Market worth US$ 2.2 Billion in 2010
» US Drug Spending – Reaching Soaring Rates
» Global Genetic Testing Market worth US$ 1.5 Billion, to Grow Significantly
 
Related Research Reports
Related Research News
May 03, 2010
New Product Launches Led US Pharma Market to Grow Strongly in 2009
Apr 30, 2010
India to be Among Top 10 Drug Producers by 2020
Apr 05, 2010
China ? On the Way to Become Third Largest Pharma Market
Jan 25, 2010
Indian Government to Set Up Special Zones to Boost Pharma Exports
Check out our latest reports on What’s New page.
Not able to find the data you are looking for?
Consider requesting a
Custom Research Proposal.
Home | About Us | Careers | Request a Quote | Discounted Reports | Contact Us | Resources | Add URL | FAQ | Upcoming Reports
Copyright © 2012, RNCOS, 2002-2012
Phone : +91 (120) 4224700/01/02/03 Fax : +91 (120) 4224707